Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,580.25
(
-0.67%
)
US TECH 100
23,538.00
(
-1.08%
)
Dow Jones
45,850.68
(
-0.81%
)
Brent Oil
105.36
(
-1.15%
)
Bitcoin
69,595.11
(
-2.31%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 164856

Wednesday, 06/11/2014 2:36:04 PM

Wednesday, June 11, 2014 2:36:04 PM

Post# of 257259

CEO also said Teva will continue to detail regular Copaxone even if they get FDA approval for the thrice-weekly product. This is new information.

That CEO is gone and if the new one is thinking what FRX' was thinking...

Forest Laboratories Announces Intention to Continue Marketing Both NAMENDA® TABLETS and Once-Daily NAMENDA XR® Into the Fall of 2014

https://finance.yahoo.com/news/forest-laboratories-announces-intention-continue-200100630.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now